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Introduction 
Liver transplantation is now practiced at many 
centers around the world (3). Many studies have been 
published on the results and complications of liver 
transplantation in the azathioprine era (23, 24). Since 
the introduction of cyclosporine (CyA), significant 
progress has been made in overall sw-vival after 
transplantation (22). 
We previously described high rates of infection in 
small groups of patients who received transplants 
between 1981 and 1983 in Pittsburgh (7, 11). 
However, no large, comprehensive study of infections 
in liver transplant recipients has been published 
after cyclosporine has been routinely monitored, after 
further improvement in surgical techniques (21) and 
the routine use of venous bypass (20). This is a study 
of the frequency, timing, and risk factors for infec-
tions in 101 consecutive adult liver transplant reci-
pients at the Presbyterian-University Hospital 
iPUH), University of Pittsbw-gh, from July 1984 to 
September 1985. 
Data were collected on all infections; subdivided 
according to severity; classified by major pathogen 
as bacterial, fungal, viral or protozoal infections. The 
timing and associated mortality for the most fre-
quent severe infections were ascertained. 
An attempt was made to determine risk factors for 
severe infection. Pretransplant factors analyzed 
were: age, sex, diagnosis, clinical status, cor-
ticosteroids and antibiotic use, and 25 laboratory 
values obtained dw-ing initial evaluation before 
transplantation. 
Sw-gical factors analyzed were: total number of ab-
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dominal sw-gical procedures and the total number 
of hours spent in sw-gery, excluding operations for 
the drainage of abdominal abscesses. 
Post-transplant factors analyzed were: the use of 
OKT3 antibody therapy, steroid boluses, and 
"recycles" and azathioprine and Cy A levels for the 
first 3 post-transplant months. The monthly mean 
of the weekly median CyA level was employed for 
analysis. 
Finally, the incidence of severe infection was 
related to the number of transfusions of packed red 
cells, platelets, fresh frozen plasma, and 
cryoprecipitate. 
~fethods 
General population 
The patient population included 101 consecutive patients who 
underwent liver transplantation between July 1984 and 
September 1985 and who survived for more than 72 hours, All 
patients were followed pro:;pectively for infection, In addition, 
patlent records were re\'iewed at the end of the study and follow-
up infonnation was obtained from referring physicians. 
Surveillance cultures for cyt.omegalovirus and herpes simplex 
viruses (huffy coat, throat wash, urine) were perfonned every 2 
to 4 weeks for the first 2 to 3 months after transplant on most 
patients, Other cultures were ordered as dictated by the clinical 
situation. 
Antibiotic prophyl.a:ris 
Patients were treated Wllh cefotaxime and amplcillin 4 g/day 
each for the 5 days after surgery. Oral mycostatin 400,000 units 
q.i.d. was given for Candida prophylaxis until discharge. 
Surgery and immunosuppression 
All patients underwent orthowpic liver transplantation as 
described by Stan) (21) either with primary anaswmosis of the 
bile duct or choledochojejunoswmy. Intraoperatively. a veno-
venous bypass was employed w shunt blood from the portal 
system and inferior vena cava to the subclavian vein (20). 
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Standard immunosuppression included cyciosporine (Cy AJ and 
corticosteroids. CyA was initially administered at a dosage of 2 
mg'kg intravenously on the day of surgery and 6 mg/kg/day 
thereafter. As soon as the patient was able to take oral medica. 
lion CyA was administered orally and adjusted to obtain blood 
levels of 800 to 1000 ng/ml by radioimmunoassay (RIA). 
One gram of methylprednisolone was administered intrave. 
nously on the day of surgery. This was reduced to 200 mg on 
the day after surgery and then rapidly tapered so that by day 
6 the patient was receiving 20 mg of methylprednisolone. Oral 
therapy with an equivalent dose of prednisone was employed 
when the patient was able to take oral medicine. 
Rejection episodes were treated with either increased doses of 
steroids or intravenous OKT3 monoclonal antibody (Ortho Pharo 
maceutical Corporation). Steroid antirejection therapy consisted 
either of 1 g boluses of Solu·Medrol or a "recycling" of oral pred. 
nIsone in which the daily dose of prednisone was raised to 200 
mg/day and tapered to maintenance levels over 5 days. 
Az.athioprine was also administered to some patients. generally 
when cyclosporine doses had to be decreased because of 
nephrotoxicity. 
Definitinns of infectinns 
We attempted to identify all infections which OCCUIT€'d after 
transplantation and categorize them according to time after 
transplantation, site of infection, type of pathogen, severity, and 
outcome. Strict criteria were employed to define infections in· 
eluded in this.study. They are as follows: 
Bacteremw was defined by the isolation in at least 1 blood 
culture of Lisll!rin ITWn.ocyWgeTU!S, Staphylococcus aureu.$, Candida 
species or aerobic gram·negative rods. For other pathogens the 
isolation of the bacteria in 2 blood cultures or in 1 positive blood 
culture and in a culture from a known site of infection was 
requIred. 
Sof/·tlSsue infectum required the isolation of a pathogen from 
a soft·tissue site showing clinical signs of infection (such as 
erythema or purulent drainage) which required surgical inter-·en· 
t ion (such as incision and drainage, or debridementl. 
Pentonltts was diagnosed if the peritoneal neutrophil count was 
<! 300 polymorphonuclear cells and if a pathogen was isolated. 
In cases where no cell counts were obtained, a Gram stain of 
pt'ntoneal fluid showing ~ 1 polymorphonuclear cell per oil field 
was sufficient. In each case an abdominal abscess was excluded 
by scanning techniques or at laparotomy. 
A bacterial abscess was defined as a collection of pus drained 
surglcally or via percutaneous catheter. In practice, all abscesses 
in this series also YIelded 1 or more bacterial pathogens on 
culture. 
The diagnosis of cholangitis required the presence offever, right 
upper quadrant pain, and elevation of liver function tests together 
WIth either e\'ldence of cholangitis on liver biopsy or isolation 
of the same organism from both the T·tube drain and blood. 
PneuITWnla required the appearance of new infiltrates on chest 
radiograph, the onset of new respiratory symptoms (cough, 
dyspnea) or hypoxemia, (PO, < 75) and the isolatIOn of bacteria 
in hea\')' gro .... 1h fTom purulent sputum. The adequacy of sputum 
was detennined microscopically by 1 of the authors, Pneu/'71lX'ystls 
pneumonia was diagnosed by 1 positive methenamine silver stain 
of opt'n·)ung biopsy or cytospin smear ofbronchoalveolar lavage 
fluid. 
When no Foley catheter was present, UT1lIat")' tract infectum was 
diagnosed by the isolation of ~ 10' bacteria (on 1 occasion) or ~ 10' 
yeast (on 2 occasions) and typical symptoms of urinary infection 
(dysuria, frequency) andior pyuria E~1M white blood cells per high 
power field). When a Foley catheter was present, either typical 
symptoms of pyelonephritis (flank pain, fever ~ 38 °C) or a positive 
blood culture with the same organism isolated from the urine 
were required. 
A diagnosis of viral syndrome due to Cytomegalovirus (CMVl 
required a temperature elevation ~PU· continuously or inter· 
mittently for at least 1 week \\.;thout another known cause and 
one or more positive CMV cultures. In addition 1 of the follow· 
ing was required: atypical lymphocyU!s ~ 3'i, white cell count 
< 4,000 per mm', or platelets less than 100,000 per mml. 
Diagnosis of tissue involvement with CMV, such as CMV 
pneuITWnUl, enteritis, or hepatitis required tissue evidence of CMV 
infection either by direct culture from tissue or by histologic 
evidence (inclusion bodies). 
Intlasit'e candidiasi.s was diagnosed by either 1) a positive blood 
culture, 2) isolation of CandidLJ from the abdomen at surgical ex· 
ploration in association with peritonitis or an abdominal abscess. 
or 3) tissue invasion demonstrated by biopsy. 
Invasive aspergillosi.s required evidence of tissue invasion on 
biopsy or at autopsy, 
Herpes simplex virus IHSV; Infection required typical oral or 
genital ulcers for diagnosis. A positive viral culture for herpes 
simplex virus was also required if a culture was submitted. Tissue 
invasion by biopsy was also acceptable evidence. Disseminated 
infection with HSV was diagnosed if 2 or more non<ontiguous 
sites were infected. 
An infection was considered to be associated with death if it 
was found at postmortem examination or if the patient was still 
under treatment for the infection when death occurred. 
In order to concentrate our analysis on clinically significant 
events we categorized infectIOns into non·sel'ere and severe infec-
tions Severe infections were those which would generally require 
hospitalization for treatment or diagnosis. 
Non·set'ere infections were bacterial sinusitis, cystitis, 
localized herpes zoster Infection, localized oral, genital and 
ophthalmic herpes. Sa'ere Infectinns included bacteremias. 
fungemias, deep tissue abscesses, peritonitis, pneumonia, wound 
infection, Clostridium difliciiR colitis. cholangitis, invasive can· 
didiasis and aspergillosis. all symptomatic CMV infections and 
deep herpes simplex tissue infectlOns such as disseminated herpes 
simplex infections, esophagitis, or hepatitis. 
Statistics 
Proportions were analyzed with chi·square test or if the 
numbers were small. Fishers exact test; means were compared 
with Student's t·test. 
Results 
Description of the population 
The study population consisted of 101 consecutive 
adult patients who underwent liver transplantation 
at PUH (Presbyterian University Hospital) between 
July 1984 and September 1985. The mean follow-up 
was 394 ± 219 (S.D.) days and 58 patients were 
followed for more than a year. The mean age was 
39 years and the median age was 41 years. 
Table 1 shows the underlying diagnosis and sex 
--_._._-------_. 
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of the recipients. Of the 101 patients, 39 were men 
and 62 were women. The diagnoses are divided in 
3 main categories: hepatocellular diseases, 
cholestatic diseases, and a group of other diseases 
that could not be categorized. The most frequent 
diagnoses were: primary biliary cirrhosis (31 pa-
tients), chronic active hepatitis (17 patients) and 
sclerosing cholangitis (16 patients), and these 
accounted for 60% of the patients who received 
transplants. 
lncidence of infections after liver transplantaiWn 
and mortality , 
Table 2 shows the frequencies of total infections 
and severe infections in the population. As can be 
seen, 839c of all patients had an infection after 
transplant and 67% had severe infections. Almost all 
bacterial, fungal, and protozoal infections were 
severe, but less than one-half of viral infections 
(0,2610.64 = 40%) were severe. Most non·severe viral 
infections were oral or genital herpes simplex 
infections. 
TABLE 1. Underlying diagnosis of 101 liver transplant 
recipients 
Diagnostic Category Male Female Total 
Hepatocellular 135 patients) 
Chronic active hepatitis 4 9 13 
CirrhOSIS. unknown etiology 3 3 6 
Alpha·l antitrypsin deficiency 2 2 4 
Chronic active hepatitis B 4 0 4 
Hemochromatosis 1 1 2 
Alcoholic cirrhosis 0 2 2 
Hepatoma after CAHB* 1 1 2 
Wilson disease 0 1 1 
Toxic-Thorotrast related 1 0 1 
Cholestatic 151 patients) 
Primary biliary cirrhosis 5 26 31 
Sclerosing cholangitis 9 7 16 
Secondary bIliary Cirrhosis 0 3 3 
Cystic fibrosis 1 0 1 
Others 115 patients) 
Other liver tumors 3 4 7 
Caroh disease 2 1 3 
Fulminant hepatitiS 1 2 3 
Trauma 1 0 1 
Budd·Chian syndrome 0 1 1 
Total 39 62 101 
'CAHB = chronic active hepatitis with hepatitiS B infection, 
TABLE 2. Frequency of different infections in the study 
population 
Episodes of Infection 
'1 Patients Infected per Patient· 
Type of 
Infection All Severe All Severe 
Bacterial 59 54 0,89 0,79 
Viral 53 24 0,64 0,26 
Fungal 18 16 0,21 0,18 
Protozoal 12 12 0,12 0.12 
Total 83 67 1.86 1.35 
• Abbreviated EIP in Tables 4, 5, 6, 8, and 9. 
TABLE 3. Severe infections and those associaU!d with 
23 deaths in 101 patients 
Number of Associated 
Infection Episodes with Deaths 
Intra·abdominal abscess 16 5 
Bacterial pneumonia 15 6 
Soft tissue infection 10 2 
Cholangitis 9 3 
Peritonitis 7 3 
Bacteremia, unknown source· 7 5 
Pyelonephritis 7 0 
Pseudomembranous colitis 6 0 
Line sepsis 2 0 
Endocarditis 1 0 
Cytomegalovirus disease 22 5 
Herpes simplex disease 3 3 
Disseminated varicella 1 1 
Invasive candidiasis 14 10 
Aspergillosis 4 4 
Pneurr!IXj'stis carinii pneumonia 11 3 
Toxoplasmosis 1 0 
Total 136 episodes 
"There were 33 episodes ofbacteremias; 26 were of known origin 
and are included in discussion of infection episode at specific 
sites (see text), 
The overall mortality in the population was 26% 
(26/101). Twenty·three of the 26 deaths (89%) were 
associated with infection. The last death in the series 
occurred 357 days after transplantation. Most pa-
tients who died had multiple infections as well as 
other posttransplant complications so that a unique 
cause of death could not always be determined. 
Table 3 shows all severe infections associated with 
23 deaths. The most frequent severe infections were 
CMV disease (22 cases), abdominal abscesses (16 
cases), bacterial pneumonias (15 cases), invasive Can-
didn (14 cases) and Pneumocystis pneumonia 01 
cases). Invasive candidiasis was the infection most 
often associated with a fatal outcome. Other infec-
tions which were frequently associated with deaths 
were intra·abdominal abscesses, cytomegalovirus in-
fection, bacterial pneumonias, and bacteremias 
without a source. In order to concentrate the analysis 
on the most important infections, the remainder of 
this report will confine itself to the analysis of time 
of occurrence, clinical presentation, and risk factors 
for severe infections. 
lncideTl.C1! and time of occurrence of severe infections 
Figure 1 shows the number of episodes of infections 
per patient per year (incidence) and the time of oc-
currence of severe infections after liver transplan-
tation in the 101 patients. The rates of infection are 
based on the number and the length of follow-up of 
surviving patients during each time interval. 
The most critical period for severe infections was 
the first 2 months after liver transplantation. This 
was true for severe bacterial, viral, and fungal in-
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fections. Severe viral and fungal infections which oc· 
curred more than 2 months after the initial 
transplant surgery all occurred within 65 days of a 
retransplant operation. Protozoal infections occurred 
at a constant rate during the flrst 6 months but were 
not diagnosed after that time. 
Of 17 severe infections that occurred more than 6 
months after transplantation, 16 were bacterial. The 
1 ith case was fungal. This was a case of 
disseminated Candida infection in a patient 4 days 
after retransplantation \\;th a third allograft. 
Clinical manifestaiions 
We describe in detail below the 136 most frequent 
severe infections, listed in Table 3. In some cases, 
data on the non·severe infections are given to round 
out the descriptions. 
Abdominal abscesses: There were 9 abdominal and 
7 liver abscesses. The 9 abdominal bacterial 
abscesses occurred in 7 patients and 4 of them (44%) 
were associated with bacteremia. The shortest onset 
was 9 days after liver transplantation and the 
longest was 331 days after the original transplant 
operation, but only 86 days after a third allograft. was 
placed. Seven of the 9 abscesses (77%) were diag-
nosed within 30 days of a preceding abdominal 
operation. 
Five abscesses were diagnosed by computerized 
scanning or ultrasound, and 1 was diagnosed at 
laparotomy after a plain abdominal film showed air 
under the diaphragm (secondary to colonic perfora-
tion). The other 3 had radiologically guided aspira-
tion after clinical diagnosis_ The location of the 
abscesses was quite variable. Splenic, pericolic and 
pelvic abscesses were also seen in addition to 
abscesses around the liver. All abscesses were treated 
with drainage and antibiotic therapy. Three (33%) 
were associated with death. 
Seven liver abscesses were diagnosed in 6 patients. 
Five of the 7 abscesses occurred less than 30 days 
after liver transplantation or a subsequent ab-
dominal operation. One abscess occurred 1 day after 
a third allograft was placed. The latest onset was 14 
months after transplantation and this abscess was 
thought to be secondary to stenosis of the hepatic 
artery. All of the patients with liver abscesses had 
technical problems involving the implanted liver. 
These complications included thrombosis of the 
hepatic artery and inferior vena cava (2 patients), 
biliary leak (1 patienO, biliary sludge (1 patient), and 
a tear in the donor liver (1 patient). 
The organisms involved were Enterococcus, aerobic 
gram·negative enteric organisms, and anaerobes. 
Four of 7 patients (57%) were bacteremic. The 
diagnosis was made by computerized tomographic 
(eT) scan or ultrasound in 6 cases and at autopsy 
in 1 case. 
Bacterial pneumoniaS-o There were 15 episodes of 
bacterial pneumonia in 14 patients, 3 of whom were 
men and 11, women. Six (40%) of the episodes had 
a fatal outcome. Of the 15 episodes, 10 were 
nosocomial and 5 were community·acquired 
pneumonias. Only 2 03%) of the pneumonias were 
associated with bacteremia. Seven episodes (70%) of 
nosocomial pneumonias occurred while the patient 
was intubated. Aspiration was documented in the 
other 3 episodes of nosocomial pneumonia, and they 
were diagnosed \\;thin the fIrst week after transplan· 
tation. One episode of nosocomial pneumonia was 
caused by S. aureus and the remainder were caused 
by aerobic gram· negative bacteria: Pseudorrwnas 
aeruginosa (4 episodes), Enterobacter cloacae (2 
episodes), E. aerogenes (2 episodes), P. maltophilia. (1 
episode) and Acinetobacter (1 episode). The 
community-acquired pneumonias were due to S. 
aureus (2 episodes), Pneumococcus (2 episodes) and 
Escherichia. coli (1 episode\. Respiratory secretions for 
cultures were obtained either by suction of deep 
tracheal secretions (7 patients), bronchoscopy (4 pa-
tients or expectorated sputum (4 patients). 
Soft-tissue infections: There were 10 episodes of soft-
tissue infection in 9 patients. Only 3 episodes were 
associated with bacteremia. Two of these episodes oc-
curred in 1 patient and were associated with his 
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death. This patient developed a Streptccoceus reeium 
abdominal wound infection 16 days after transplan-
tation; 13 days later an abdominal wall abscess \\;th 
Klebsiella pneunwnia and Citrobacter freundii oc-
curred at the same site. 
The onset of soft-tissue infection varied from 6 days 
to 230 days after transplant surgery but in 8 of 10 
episodes it occurred within the first month after 
transplantation. Eight cases were infections of the 
abdominal wound or abscesses in the abdominal wall 
near an abdominal wound. The other 2 cases were 
an infected hematoma of the leg and a perirectal 
abscess. The organisms involved were: gram-
negative aerobes (3 cases), gram-positive aerobes (2 
cases), and mixed flora (5 cases)_ 
Cholangitis: There were 9 well-defined episodes of 
cholangitis in 6 patients. Eight of 9 episodes were 
associated with technical surgical problems: biliary 
duct strictures (5 patients), complicated surgery re-
quiring vascular grafts (2 patients), and biliary leak 
(1 patient). A temperature elevation was present dur-
ing all 9 episodes (37.7 °C-40°C) but only 4 (44Ck) of 
the 9 episodes were associated with bacteremia. The 
organisms involved were: aerobic gram· negative rods 
(2 episodes); aerobic gram· positive cocci (2 episodes); 
anaerobes (1 episode); multiple organisms (4 
episodes). The 4 bacteremic episodes were due to K. 
pneunwnia, S. feealis, B. fragilis and P. aerugirwsa 
LDgether with S. fecalis. 
One patient with biliary duct strictures had 4 
recurrent episodes of cholangitis. The shortest onset 
of cholangitis was 3 days after very difficult surgery 
and the longest onset was 552 days after transplant 
surgery in a patient with biliary duct strictures. 
Three episodes of cholangitis were associated with 
death (33Ck). 
Peritonitis: Nine episodes of peritonitis occurred in 
the series. Six were due to bacteria (gram·negative 
aerobic, 2; gram·positive aerobic cocci, 3; anaerobe, 
1) and 3 to Candida species. Two bacterial episodes 
were associated with bacteremia. Although 7 
episodes were associated with temperature eleva-
tions between 37.6°C and 40°C, 2 patients with Can-
dida infection did not have fever. Five episodes were 
related to biliary leaks. One of these occurred after 
extraction of a t-tube and another followed at-tube 
cholangiogram. The other cases were associated with 
hepatic artery thrombosis (2 cases) and colonic per-
foration (1 case). Three (33%) of the 9 episodes of 
peritonitis were associated with death. 
Bacteremias: Thirty-three bacteremias occurred in 
26 patients, including 13 women and 13 men. Twelve 
of the bacteremias (36%) had a fatal outcome. The 
mean onset was 132 days after transplantation and 
the range was 5 to 552 days. The most common 
source was the abdomen (33%), followed by the 
urinary tract (21%). The other bacteremias with a 
known source arose from wound infection (9%), in-
travenous catheters (6%), pneumonia (6%), and en-
docarditis (3%). Twenty-one percent of the 
bacteremias did not have a known source. It is 
likely that most of these originated in the abdomen. 
Fifty-one percent of the blood cultures with single 
isolates were gram-negative aerobic bacteria, 27% 
were gram-positive aerobic organisms, and 9% were 
anaerobes. Twelve percent of positive cultures had 
multiple isolates. 
CMV disease: Symptomatic CMV occurred in 22 
patients (22%) in this series. These patients in-
cluded 15 cases of CMV viral syndromes, 6 cases of 
disseminated disease and 1 case of isolated CMV 
hepatitis. Of these 22 patients, 10 were males and 
12 females. Their mean age was 39 years and the 
mean onset was 37 days after transplantation (range, 
16-149 days). Twenty-one of 22 episodes occurred 
within 7 weeks of a transplant operation. 
The most common presentation of CMV disease 
was fever with neutropenia and atypical lym-
phocytosis 04 patients). Eleven patients (50%) had 
both neutropenia and thrombocytopenia. The mean 
duration of fever was 13 days (range, 7-24). The pa-
tient who developed CMV hepatitis had a 
temperature elevation ov~r 40°C for 12 days and 
22% atypical lymphocytes on her peripheral blood 
smear. 
Five of 6 patients with disseminated disease were 
diagnosed at autopsy. Their disease involved multi-
ple organs, including both the liver and lung in 5 
patients. Four of these patients developed a picture 
of "adult respiratory distress syndrome" on chest 
radiograph and required intubation and high end ex-
piratory pressure for ventilation. The 1 patient with 
disseminated CMV who survived had hepatitis and 
gastritis but did not develop CMV pneumonitis. All 
6 patients with disseminated disease had received 
OKT3 therapy as treatment for rejection. 
Herpes simplex infections: Thirty-five of the 101 
liver transplant recipients (34Ck) had herpes simplex 
(HSv) infections. Of these. 32 patients had non-
severe mucocutaneous disease. Twenty.three pa-
tients had isolated oral herpes simplex infection; 7 
patients had isolated genital herpes infection; 1 pa-
tient had infection of both the genitals and the skin 
of a lower extremity; and 1 patient had herpes 
stomatitis, genital herpes, and herpes keratitis at dif-
ferent times. 
'Three patients had severe visceral herpetic infec-
tions (Table 3). These included a case of disseminated 
HSV infection in multiple organs. 1 case of isolated 
HSV infection of a third hepatic allograft and 1 case 
of HSV esophagitis and colitis. These 3 cases were 
diagnosed at postmortem examination. Fifty percent 
of herpetic infections occurred within 3 weeks after 
a transplant operation. Most patients with non-
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severe HSV infections were treated with oral or in-
travenous acyclovir and all their infections healed_ 
All 3 patients with visceral disease died. 
Varicella-zoster: There were 5 cases of herpes zoster 
infections (5%), 4 of them with only localized skin 
manifestations. Their range of onset was 116 to 551 
days. The fIfth case had disseminated varicella with 
viremia and hepatitis, and infection occurred 28 days 
after transplantation. 
Candida infections: There were 14 invasive Can-
dida infections in 13 patients. All occurred within 
2 months of a liver transplant operation. The latest 
infection was 183 days after the original transplan-
tation, but only 4 days after a third allograft was 
placed. 
Of the 13 patients, 7 had histological evidence of 
candidal tissue invasion. Five of these patients had 
disseminated disease, 1 had invasive esophagitis, and 
1 had necrotizing cystitis with invasion of Candida 
into the bladder muscle. The other cases were 
diagnosed either by isolation of Candida from the 
blood stream (3 patients) or by isolation of Candida 
at laparotomy from peritonitis or an intra-abdominal 
abscess (3 patients). 
The species of Candida isolates were C. albicans 
(10 isolates), C. glabrata (3 isolates) and C. tropicalis 
(1 isolate). 
Ten of the patients with invasive candidiasis (77%) 
died. In 4 of these patients the diagnosis was not 
suspected before death and established only at 
postmortem examination. 
Nine patients received amphotericin B for an 
average of 18 days (range, 7-40). The 3 patients who 
survived included 2 patients with candidemia and 
1 with Candida peritonitis. 
Deaths in these patients were not always 
umquel~ due to Candida infection, as 11 of the pa-
tients WIth Candida infection also had either severe 
bacterial infections and/or viral infections during 
follow-up. 
Aspergillosis: There were 4 patients with systemic 
Aspergillus infections in this series; all of these in· 
fections were fatal. The sites of involvement were in 
the lung alone (1 patient), the heart, stomach and 
liver (1 patient) and the lung and brain (2 patients). 
All but 1 patient had a postmortem examination. 
Three patients were suspected to have fungal infec-
tion during life and were treated with 9 to 24 days 
of amphotericin B. One patient was not treated and 
on postmortem examination was found to have 
Aspergillus pneumonia. ' 
Pneumoc),stis carinii pneumonin (PCP): Eleven pa-
tients in this series, including 7 women and 4 men, 
had pcp infection. The mean onset was 89 days after 
liver transplantion (range, 20-140). Two cases that 
occurred quite early after transplantation (on days 
20 and 37) differed from the cases that occurred later 
in thatthey presented with localized chest infiltrates 
and only a few organisms were found by 
methenamine silver stain of cells obtained by 
broncho-alveolar lavage. Nine cases occurred bet-
ween 53 and 140 days after transplantation and 
presented with diffuse interstitial infiltrates. The 
symptoms at presentation were fever 000%), cough 
(45£K), and shortness of breath (30%). All 11 patients 
were started initially on a regimen oftrimethoprim-
sulfamethoxazole, but 5 patients were treated later 
with pentamidine or a combination of pentamidine 
a.nd trimethoprim-sulfa.methoxazole because of per-
SIstent fever and hypOXia. There were 3 fatalities in 
the series and all 3 of them were complicated by 
CMV pneumonitis. 
Toxoplasmosis: There was only 1 case of tox-
oplasmosis in this series. This was a 57-year-old 
woman who became confused 39 days after 
transplantation and developed lymphocytic men-
ingitis. The diagnosis was made after the patient had 
recovered when Toxoplasma gondii was isolated in 
tissue culture of a buffy coat sample of her blood. 
This case has been reported in greater detail 
elsewhere (13). 
Pretransplantation risk factors for infection 
The frequencies of infection expressed as number 
TABLE 4. Frequency of severe infections and mortality in relation to sex, age and underlying ruagnosis 
'k Patients q Patients 
Number E.'? infected died 
I. Sex 
Males 39 1.31 64 28 
Females 62 1.37 69 24 
II. Age 
~41 YT 52 1.25 61 19" 
>41 YT 49 145 69 39" 
III Underlying Diagnosist 
Cholestatic disease 51 120 61 24 
Hepatocellular disease 35 146 74 31 
Other 15 1.73 73 20 
·P-O.06 by Fisher's Exact Test. 
tSee Table 1 for details of diagnosis. 
1 
, 
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of episodes of infection per patient and mortality 
related to demographic variables of sex, age, and 
underlying diagnosis are shown in Table 4. Infection 
frequencies and mortality rates did not differ for men 
or women or for patients older or younger than the 
median age, although there was a trend for mor-
tality to be higher in patients older than 41 years 
(p = 0.06; Fisher's Exact Test). 
When patients were allocated to diagnostic 
categories of hepatocellular disease (35 patients), 
cholestatic disease (51 patients) and miscellaneous 
liver diseases (15 patients), infection rates were noted 
to be slightly, but not significantly, lower in patients 
with cholestatic liver disease than in patients with 
other diagnoses. In addition, we did not find 
significantly higher or lower infection rates related 
to any common specific diagnosis such as chronic ac-
tive hepatitis, primary biliary cirrhosis, or scleros-
ing cholangitis. 
We attempted to define risk factors for infection 
by assessment of the effect of pretransplant clinical 
and laboratory variables. Eight discrete clinical 
variables in the pretransplant period were in-
vestigated for their possible association with infec-
tion (Table 5). The use of corticosteroids in the 
preceding month; the use of intravenous antibiotics 
in the preceding month; the presence of ascites, 
encephalopathy, a history of gastrointestinal 
bleeding; the presence of a thrombosed portal vein; 
the presence of a biliary drain; and a positive 
hepatitis B surface antigen test were not associated 
with a significantly higher or lower frequency of in-
fection after transplantation_ 
Patient charts were investigated for 25 
pretransplant laboratory studies ordered which 
might be associated .... ;th the frequencies of infection. 
Not all test results were available on all patients, 
but the mean number of results available was 21 per 
patient. 
Twenty·five blood laboratory results were 
TABLE 5. Pretransplant clinical variables and frequency 
of severe infection after transplantation 
Variable 
Steroid use 
Ascites 
Gastrointestinal bleeding 
Encephalopathy 
Biliary drain 
Thrombosed portal vein 
Antibiotics i.v. 
Positive HBsAg 
No. ~oK 
with (EIP) without (E,P) 
17 <1.41) 84 n.33) 
61 (1.26) 40 n.47) 
52 (1.44) 49 11.24) 
37 (1.21> 64 (1.42) 
8 (1.25) 93 (1.35) 
8 <0.62) 93 (40) 
15 (1.46) 86 (1.32) 
7 12.0) 94 (1.29) 
examined for their possible relationship with later 
infection frequencies including serum creatinine, 
total white blood cells count, polymorphonuclear 
cells, lymphocytes, platelets, hematocrit, T-helperlf-
suppressor ratio, total T cells, T-helper lymphocyte 
count, T·suppressor lymphocyte count, total 
hemolytic complement (CHI00), quantitative im-
munoglobulins (including IgG, IgM, and IgA), 
albumin, globulin, iron, ferritin, total bilirubin, 
aspartate aminotransferase (AST), alanine 
aminotransferase (AL T), alkaline phosphatase, 
gamma glutamyl transferase, prothrombin time and 
partial thromboplastin time. Only 2 results showed 
a significant association with infection (Table 6). Pa-
tients with aT-helper/suppressor (HJS) ratio of ::!5 2.8 
eN = 33) had more episodes of severe infection (1.66 
per patient vs. 0.85 per patient, P < 0.02, t-test). Also, 
patients with ALT (SGPI') values> 60 IUIL had an 
infection frequency of 1.56 episodes (N =50), while pa-
tients with AL T values ::!5 60 (N =48) had an infec-
tion frequency of 0.97 episodes (P < 0.05, t-test). 
The analysis was further made for subcategories 
of bacterial, viral, fungal, and protozoal infections 
with respect to the above 2 laboratory tests. We 
found that patients with lower HIS ratios had signifi-
cant higher frequencies of severe viral (p < 0.02) and 
fungal <P < 0.01), but not bacterial or protozoal, in-
fection. Patients with higher levels of ALT, on the 
other hand, did not have higher infection frequen-
cies in any specific pathogen category. 
Surgical risk factors for infection 
Table 7 shows the surgical procedures performed 
on 101 liver transplant recipients. There were a total 
of 127 transplant operations and 69 other operations. 
As shown, 80 patients had a single transplant 
operation. The reasons for retransplantation in-
cluded: primary liver failure n 1 cases); technical 
problems (7 cases) including 5 cases of hepatic·artery 
thrombosis, 1 case of aortic graft thrombosis and 1 
case of hepatic artery stenosis: rejection (6 cases); and 
infection (2 cases). One infected patient had recur-
rent fulminant hepatitis B of the transplanted liver 
and the other had bacterial liver abscesses refrac-
tory to antibiotic therapy. 
Figure 2 shows the rate of severe infections in rela-
tion to total surgical time. For this analysis time 
spent in the operating room for drainage of abscesses 
was excluded. As shown the infection rates rose 
steadily with increasing surgical time. The overall 
infection frequency in patients who spent more than 
TABLE 6. Correlation of pretransplant laboratory values with infections afU!r transplantation 
Lab. No. Pts. Median Pts. > Pt.s. :S 
Variable tested value Median ElF Median EIP P 
T·helperlI'.suppressor ratio 61 2.8 28 0.85 33 1.66 < 0.02 
ALT (SGPTl· 98 60 lUlL 50 1.56 48 0.97 <0.05 
• ALT (SGPTI = alanine aminotransferase (serum glutamic pyruvic transaminase) 
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TABLE 7. Summary of 196 surgicaJ procedures in 101 
liver transplant reci~~c~s _____ _ 
Transplant operations 1127 operations) 
One transplant operation 180 x r = 80) 
Two transplant operations 116 x 2 = 32) 
Three transplant operations 15 x 3 = 15) 
Other operations 169 operations) 
Drainage of abdominal abscesses 116) 
Treatment of intra-abdominal bleeding (15) 
Repair of biliary leaks (} 1) 
Laparotomies with no findings (5) 
Tracheostomies (5) 
Repair of biliary strictures (4) 
Treatment of gastrointestinal bleeding 13) 
Others 110) ~~------------------------------
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FIG. 2. Frequency of severe infections In relation to total 
operative time per patient in hours. 
12 hours in the operating room was 1.97 episodes/pa-
tient (E/P) versus a frequency of 0.97 infections per 
patient in those who spent less than 12 hours in the 
operating room (p < o.oon Also patients with more 
than 1 abdominal operation had a higher infection 
frequency compared to those who had only 1 
transplant operation and no other laparotomies n.95 
E? vs. 0.86 E,?, P < O.OOll. 
The rates of severe infections with different 
pathogen types for patients who spent more or less 
than 12 hours (the median) in the operating room 
was also analyzed. Significant differences were noted 
for severe bacterial infections (P<O.OI), severe 
fungal infections « 0.001), and severe viral infec· 
tions (p < 0.05). Remarkably, all 18 severe fungal in-
fections occurred in patients who spent more than 
12 hours in the operating room. 
Table 8 shows frequencies (EIP) of severe infections, 
in relation to the type of biliary drainage. The groups 
analyzed were 65 patients who had only a 
choledocho-choledochostomy with t-tube placement 
(CC) and 36 patients who had a choledocho-
jejunostomy (CJ) performed either at the initial 
transplantation or later. The analysis is further 
broken down into patients who had only 1 transplant 
operation and those who had more than 1 transplant 
operation. Patients who had only 1 transplant opera-
tion had very similar frequency of infection whether 
they had a CC or a CJ. By contrast, the patients who 
had more than 1 transplant operation had a higher 
frequency of infection if a CJ was employed (3.25 vs. 
1.50 EIP, P < 0.02)_ This was then reflected in an 
overall higher frequency of infections in patients 
with CJ compared to those with CC (1.72 vs. 1.14 
EIP, P<0.05). 
The 11 patients who underwent more than 1 
transplant operation and had biliary drainage via 
a CJ had a very high mortality rate (10/11 = 91%). 
These 11 patients had a total of 27 transJ1lant opera-
tions. Four of the patients had only CJs and 7 pa-
tients had an original transplantation employing a 
t-tube but were switched to CJ later_ 
Non-surgical risk factors for infection 
The frequency of severe infections by various 
pathogens was analyzed in relation to the use of ad-
ditional immunosuppressive agents and steroids. The 
factors analyzed were the use of OKT3, the use of 
azathioprine for more than 7 days, and the ad-
ministration of greater than 5 (the median number) 
of recycles or boluses of steroids. For the purpose of 
analysis a steroid bolus was considered to be 
equivalent to a steroid recycle. There was no signifi-
cant association between the use of azathioprine or 
frequent steroids and higher frequencies of infection 
(1.32 E/P vs. 1.37 EIP for azathioprine, and 1.55 EIP 
\'s. 1.21 EiP for steroids). The only significant result 
was that patients given OKT3 had a higher fre-
quency of protowal infections (p < 0.05). We could not 
demonstrate a higher frequency of severe viral in-
fections in patients receiving OKT3 (0.27 EIP vs. 0.23 
EIP). However, when we analyzed all viral infections 
together (severe and non-severe), we did find that pa-
tients on OKT3 had higher frequency of viral infec-
tions than patients not receiving OKT3 (0.76 EIP vs. 
0.46 E,?, P < 0.05, t-test). 
The frequencies of infection were analyzed in rela-
TABLE 8. Severe infections in relation to type of biliary 
drainage 
Pts ...... ith 1 Tx 
Frl'quency of infection IE!P) 
Drainage Procedure 
CC· CC, CJt P 
55 
1.07 
25 
1.04 P>0.05 
Pts. with more than 1 Tx 10 11 
Frequency of infection (E!P) 1.50 3.27 P<O.02 
All patients 65 36 
Frequency of infection (E!P) 1.14 1.72 P<O.05 
Abbreviations: Tx = transplantation, CC = chodedocho-
choledochostomy, CJ = choledocho-jejunostomy. 
·Patients with CC with t·tube only. 
tPatients with CJ or patients who started with CC but then were 
converted to CJ. 
~-
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TABLE 9. Blood products and severe infections after liver transplantation 
_._---- ----
Blood Median No. pts. No. pts. 
Product units/pt > median EP S Median E/P P 
---------- -
RBC 25 51 1.66 50 1.02 <0.02 
FFP 30 51 1.66 50 1.02 <0.02 
PLT 29 52 1.51 49 1.16 NS 
Cryo 6 45 1.55 56 1.17 NS 
Abbreviations: RBC = red blood cells. FFP = fresh frozen plasma. PLT = platelets. Cryo = cryoprecipitate. NS = not significant. 
tion to high or low mean levels of Cy A. For each pa-
tient a monthly mean was calculated of 4 weekly me-
dian Cy A levels. Average Cy A levels for all patients 
were 1002 nglml (range, 519-1855) in the fIrst 
month, 1046 ng/ml (range, 257-2068) in the second 
month, and 946 ng/ml (range, 190-1720) in the third 
month after transplantation. Oddly, we could not 
document higher rates of infections in patients who 
had higher levels ofCyA. On the contrary, we found 
a significantly higher overall frequency of infections 
in patients who had lower levels of cyclosporine dur-
ing the second post-transplant month. This appeared 
to be related to lowering of the cyclosporine dosage 
in patients who were already infected during the first 
post-transplant month, because further analysis 
showed that the patients with lower CyA level in the 
second month had higher infection rates only in the 
first month (p < 0.001), not in the second or third 
months. 
To assess the impact of antibiotics on infection 
rates, we counted the number of days of treatment 
with non-prophylactic additional intravenous an-
tibiotics in the first 3 months after transplant opera-
tion. Sixty·five patients received additional in· 
travenous antibiotics in this time period and 36 pa-
tients received no additional antibiotics. Overall, the 
average duration of additional antibiotic administra-
tion was 9 days, and the median was S days. Patients 
who received higher than the median days of in· 
travenous antibiotics had higher rates of severe in-
fections (2.02 EIP vs. 0.68 EIP, P < 0.001, t-testl. 
'W'hen different pathogen groups were analyzed, this 
relation held for both severe bacterial and severe 
fungal infection (p < 0.001), but not for severe viral 
or protozoal infections. All 18 severe fungal infections 
in this series occurred in patients who received more 
than 5 additional days of intravenous antibiotics. 
We correlated infection frequencies with the 
number of units of different blood products received 
by the patients. The results are shown in Table 9. 
This analysis shows that patients who received more 
than the median units of red blood cells mBC) and 
fresh frozen plasma (FFP) had higher post-transplant 
infection frequencies (P< 0.02 for both RBC and 
FFP). This was not shown with platelets and 
cryoprecipitate. When severe infections were broken 
dovlD to specific pathogens, we found that patients 
who received more RBC and FFP had higher rates 
of only bacterial infections (P< 0.02) and fungal in-
fections Em<MKM1~ but not viral or protozoal infections. 
Discussion 
Liver transplantation has now become an accept-
able mode of treatment for end-stage liver disease. 
A number of previous publications, including studies 
from our own institution, have described one or 
another aspect of infections after liver transplanta-
tion (7,8, 17,27). There has been, however, no com-
prehensive study of infections in liver recipients on 
cyclosporine. In this study we attempted to provide 
a thorough description of the epidemiology and risk 
factors for all types of infections in a sizable adult 
liver transplant population. 
A comparison of the results in this study with our 
previous study, covering 1981 to 1983 (11), shows 
that although the overall percentage of infected pa-
tients (83% vs. 81%) was similar, the number of 
deaths associated with infection was significantly 
lower in the present study (23/101 = 23% vs. 17/43 
= 40%, P<O.OS). The reasons for the decline in in-
fectious mortality are not known but are probably 
related to technical advances in surgery (such as in-
troduction of veno-venous bypass during transplan-
tation) and to other improvements in patient 
management (such as the monitoring of cyc1osporine 
levels after transplantation). 
In our study the critical period for infections was 
the ftrst 2 months after transplantation. Seventy per-
cent of all severe infections and 93% of severe viral 
and fungal infections occurred during this period. 
The few severe viral and fungal infections that oc-
curred later followed retransplantation. 
By contrast, 94% (16/17) of infections occurring 
later than 6 months after transplantation were 
bacterial. ~1Mst of these were routine infections like 
pneumonia, urinary tract infection and cholangitis, 
infections that may be seen in a non-immuno-
suppressed surgical population. Pneumocystis infec-
tions occurred throughout the first 6 months after 
transplantation but were not diagnosed thereafter. 
High rates of fungal infection were first 
documented by &hroter et al (18) in liver recipients 
receiving azathioprine and prednisone. We found a 
42% incidence of fungal infection in adult liver reci-
pients receiving Cy A and prednisone between 1981 
and 1983 (27). Significant associations with the oc-
currence of fungal infections in that series were the 
pre- and post- transplant use of corticosteroids and 
antibiotics, and the length of surgery. We also found 
previously that patients with a diagnosis of primary 
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biliary cirrhosis had significantly fewer fungal in-
fections and a lower death rate. 
The present series shows that severe fungal infec-
tions are still a serious clinical problem 06%- in this 
series) and lead to high mortality (13/16 = 81%). 
However, the decline in incidence of fungal infections 
from the previous series is highly significant 
(P<O.OOl) and probably represents the most impor-
tant improvement in mortality due to infections in 
our liver transplant recipients. 
In this series, the pretransplant use of antibiotics 
and pre- and post-transplant use of steroids were not 
found to be significant risk factors for fungal infec-
tion, but there continued to be very strong associa-
tions between the occurrence of severe fungal infec-
tions and an increased use of post-transplant 
antibiotics and prolonged operative time. As in 
previous studies of liver transplant recipients, the 
impoltant fungal pathogens were Candida and 
Aspergillus and all such infections occurred in 
hospitalized patients_ 
Although a few cryptococcal infections have oc-
cWTed in our liver transplant population. they were 
not seen in this series and appear to occur in 1 ~ or 
. less of liver recipients in the first year after 
transplanta tion. 
The reason for the decline in the rate of fungal in-
fection in the present series is unknown but may 
relate to better operative techniques, more judicious 
use of antibiotics, and better control of immuno-
suppression--()r greater willingness to institute em· 
piric amphotericin B therapy in high·risk patients. 
The strong association found here between severe 
fungal infections and prolonged surgery might form 
the basis for future investigations of antifungal pro-
phylaxis in patients with prolonged operative time. 
Eleven of 33 bacteremias (33.3lk) in this series 
originated in the abdomen. Many bacteremias 
.... ithout known source probably also originated in the 
abdomen. Like fungal infections, early bacterial ab-
dominal infections (abdominal and liver abscesses, 
peritonitis, cholangitis) were associated with pro-
longed surgical time and increased number of abo 
dominal operations. Only about 50<k of the patients 
in this series had a single abdominal operation. The 
common reasons patients returned to the operating 
room were for retransplantation or abdominal ex-
plorations for bleeding, biliary leak, and biliary stric-
ture. Biliary complications and other technical prob-
lems are highly associated with infections after liver 
transplantation (14, 15, 25). Hepatic artery throm-
bosis is a particularly serious technical complication 
occurring in 3.4% of adults. It may lead to infectious 
complications such as cholangitis, infected bile col-
lections, and liver abscesses, and often culminates 
in retransplantation (26). The bacterial pathogens en-
countered were those typically seen in hospitalized 
surgical patients with a predominance of gram-
negative enteric rods. 
Eight of the 101 patients (8%-) developed infection 
of the abdominal wound by our criteria. This rate 
is quite similar to the rates of wound infection after 
elective biliary tract surgery (6) or other clean-
contaminated operations (5). It should be noted that 
in order to use clear-cut criteria we only included 
cases in which incision and drainage or surgical 
debridement were employed. Thus, our rate should 
be considered a minimal estimate of the rate of 
wound infection after liver transplantation. Minor 
degrees of erythema at the surgical wound are quite 
difficult to evaluate in these patients and although 
these often prompted antibiotic therapy, their clinical 
significance is unclear. 
Symptomatic cytomegalovirus infections were the 
most common severe infection after liver transplan-
tation (22 episodes). Six patients in the series had 
disseminated CMV and 5 (83%) of them died. 
Although our analysis did not demonstrate an 
association between symptomatic CMV infection and 
use of OKT3, azathioprine, or large numbers of 
steroid boluses or recycles, all 6 patients with 
disseminated CMV had received OKT3. Anti·T -cell 
globulins have been previously shown to be a risk 
factor for severe CMV infections (2, 10, 16). 
Mucocutaneous herpes simplex virus infections, 
classified as a non-severe infection, were quite com-
mon (32<k of our population), and were easily 
managed with antiviral therapy, but there were also 
3 cases of visceral HSV infection that were 
diagnosed only at postmortem examination. 
Pn.eumocystis carinii pneumonia OCCWTed in 11 pa· 
tients (1111) in this series. This rate of Pneumocystis 
infection is similar to that found in other studies of 
transplant recipients (9, 12). The significantly higher 
rate of protozoal infections in patients receiving 
OKT3 suggests that patients in this group might be 
candidates for prophylaxis with trimethoprim-
sulfamethoxazole. Interestingly, the 3 patients who 
did not recover from their pneumonia had com· 
plicating CMV disease in the lungs. Clinicians 
should be aware that other infections. particularly 
CMV infection, may accompany Pneumocystis 
pneumonia and be a cause for a poor response to 
therapy. 
We could not document any definite association 
between demographic variables of sex, age, or 
pretransplant diagnosis and infection rates, although 
there was a trend toward higher mortality rate in 
older recipients. There also appeared to be a trend 
in favor of lower infection rates in patients with 
cholestatic disease and it is possible that studying 
a larger group would have shown a significant 
difference. 
Eight pretransplant clinical variables and 25 
pretransplant laboratory values were investigated to 
see if these were associated with higher frequencies 
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of infection. The only 2 pretransplant variables 
associated with higher rate of infection were lower 
T·helperff-suppressor (HIS) ratio, and higher ALT 
levels before transplantation. The finding of higher 
AL T in association with higher rate of severe infec-
tions is consistent with our finding that patients with 
hepatocellular disease do somewhat worse than other 
patients (27). When we analyzed HIS ratios in 
various infection types, we found that lower 
pretransplant rates were associated with higher 
rates of severe viral (P < 0.02) and severe fungal in-
fection (p < 0.01), but not bacterial or protozoal in-
fections. Oddly, we found no correlation between the 
absolute number of T-helper cells or T-suppressor 
cells and the incidence of infection, suggesting that 
the balance of helper and suppressor cells was more 
important than the absolute numbers. The impact 
of pretransplant immune status on post-transplant 
infections is poorly understood and requires further 
study, but such a study might be clinically helpful 
in deciding how intensively ro apply pharmacological 
immunosuppression. 
Of all the factors influencing the rate of infections 
after liver transplantion, surgical factors appear to 
be the most important. Other authors have shown 
correlations between operative time and 
postoperative rate of infection. Shapiro et al (19) 
showed that higher risk of infection after hysterec-
tomy was associated with increased surgical time, 
and Cruse and Foord (5) showed a direct relation 
between length of surgery and infection of surgical 
wounds. 
In our series we found that more prolonged 
surgical time and increased number of abdominal 
operations were both strongly associated with more 
bacterial and fungal infections. The most striking 
finding was the fact that all severe fungal infections 
occurred in patients with more than 12 hours (the 
median) of operative time. 
Another surgical facror we found to be important 
in infections after the transplant operation was the 
type of biliary drainage. Although the type of 
drainage system did not influence the rate of infec-
tion (1.07 vs. 1.04) in patients who underwent only 
1 transplant operation, patients who had more than 
1 transplant operation had a higher frequency of in-
fection if a choledocho-jejunosromy was performed. 
There are 2 possible explanations for this finding. 
The most likely is that patients who require conver-
sion to lWux-en-Y or repeat lWux-en-Y are intrin-
sically a higher risk group. However, the finding 
may also reflect a higher risk of surgical entry into 
the bowel in the post· transplant period, when it is 
more likely to be colonized with antibiotic-resistant 
bacteria and Candida. While the choice of drainage 
procedure is generally determined by the technical 
surgical situation, it is still useful ro recognize that 
repeat CJ is a very high-risk situation. 
In the analysis of severe infections in relation to 
immunosuppression (excess steroids, OKT3, 
azathioprine), the only significant finding was in pa· 
tients who received OKT3 therapy. While we could 
not show that the overall frequency of infection was 
increased by OKT3, protozoal (Pneunwcystis) infec-
tions and all viral infections (both severe and non-
severe), were more common. Monoclonal antibodies 
including OKT3 provide powerful means to treat re-
jection (4), but their impact on infection remains to 
be comprehensively studied. 
Serious infections compromise the course of many 
patients after liver transplantation. We have shown 
a historical decline in infectious mortality when com-
paring our current results with previous studies. It 
is likely that infections will be reduced even further 
as technical advances are made in the transplant 
operation, and better noninvasive tools are developed 
to diagnose abdominal infections. 
Fungal infections are still a serious clinical prob-
lem. Early diagnosis of Candida and Aspergillus in-
fections by serological methods still needs further 
study (1). Over the years we are moving to earlier 
empiric treatment of liver transplant recipients at 
high risk for fungal infections, before a definitive 
diagnosis is made. This study further defines par-
ticular risks for fungal infection, especially pro-
longed surgery and prolonged antibacterial treat· 
ment that could form the basis for trials of prophylac-
tic antifungal therapy. Unfortunately, the only 
reliable drug now available for the treatment of in-
vasive candidiasis or aspergillosis is amphotericin B. 
Effective and less roxic alternative antifungal agents 
are needed. 
Summary 
We studied infections in 101 consecutive patients 
who underwent liver transplantation between July 
1984 and September 1985. The mean length of 
follow-up was 394 days. Eighty·three percent of the 
population had 1 or more episodes of infection and 
67% of the population had severe infections. The 
overall mortality was 26/101 (26%) and 23 of 26 
deaths (88%) were associated with infection. 
Seventy percent of severe infections occurred in the 
first 2 months after transplantation. 
The most frequent severe infections were ab-
dominal abscess, bacterial pneumonia, invasive can· 
didiasis, Pneunwcystis pneumonia, and symptomatic 
cytomegalovirus infection. Patients with more than 
12 hours of cumulative surgical time had a higher 
rate of severe infections (P < 0.001), particularly 
fungal (P < 0.001) and bacterial (P < 0.01) infections. 
Also, the use of choledocho-jejunostomy was 
associated with a higher rate of infection in patients 
who had more than 1 transplant operation (P < 0.02). 
No increase in infection was found in patients who 
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received azathioprine, or more than the median 
number of steroid boluses or "recycles"; but patients 
who received OKT3 therapy had a higher rate of pro-
tozoal infections (p < 0.05). A result similar to that 
of our previous studies was a strong relation between 
the number of severe fungal infections and pro-
longed courses of antibiotics after transplant opera· 
tion (P < 0.001). 
Pretransplant manifestations of severe liver 
disease such as ascites, encephalopathy, and 
gastrointestinal bleeding were not associated with 
higher rates of infection after transplantation, but 
high serum levels of ALT were. Patients with lower 
ratios of T-helper to T-suppressor lymphocytes had 
more severe viral (P< 0.02) and fungal CP< 0.01) 
infections after transplantation. 
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